AD

The drug, molnupiravir from Merck, is intended to be used in people at risk for severe COVID-19. The FDA panel authorized its use by a vote of 13-10.

     


from USATODAY - News Top Stories https://ift.tt/3xM44JJ

Post a Comment

Previous Post Next Post